Should the term coagulopathy in cirrhosis be abandoned?

JAMA Internal Medicine

Volumn 175, Issue 5, 2015, Pages 862-863

  Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FRESH FROZEN PLASMA;

BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CLINICAL PRACTICE; CONSENSUS; ENDOTOXEMIA; FIBRINOLYSIS; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERFIBRINOLYSIS; LETTER; LIVER CIRRHOSIS; LIVER FUNCTION; PORTAL VEIN BLOOD FLOW; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION; BLOOD; BLOOD TRANSFUSION; CONTRAINDICATIONS; FEMALE; INTERNATIONAL NORMALIZED RATIO;

BLOOD COAGULATION; BLOOD TRANSFUSION; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS;

EID: 84929104668     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.90     Document Type: Letter

References (5)

1. Roberts JR, Bambha K. Balanced coagulopathy in cirrhosis-clinical implications: a teachable moment. JAMA Intern Med. 2014;174(11):1723-1724.
2. Violi F, Ferro D. Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis. Semin Thromb Hemost. 2013;39(4): 426-433.
3. Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla DC. Hypercoagulability in cirrhosis: causes and consequences. J Thromb Haemost. 2011;9(9):1713-1723.
4. Violi F, Ferro D, Basili S, et al. Ongoing prothrombotic state in the portal circulation of cirrhotic patients. Thromb Haemost. 1997;77(1):44-47.
5. Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? fact or fiction? J Hepatol. 2011;55(6):1415-1427.